Osamu Hasegawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Osamu Hasegawa has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hitoshi Yamada
Department of Orthopaedic Surgery, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan
1 shared publication - Kazuhiro Tasaki
Department of Diagnostic Pathology, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan
1 shared publication - Kazuo Watanabe
Fukushima Pathology Laboratory, Fukushima, Japan
1 shared publication - Michiyuki Hakozaki
Department of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan
1 shared publication - Shin-Ichi Konno
Department of Orthopaedic Surgery, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan
1 shared publication - Takahiro Tajino
Department of Orthopaedic Surgery, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima-shi, Fukushima 960-1295, Japan
1 shared publication
Latest Publications
- Open Access
- 7 June 2014
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 111
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
We describe a case of giant cell tumor of the proximal tibia with skip bone metastases of the ipsilateral femur in a 20-year-old man. After the neoadjuvant treatment with denosumab, plain radiographs and computed tomography showed marked osteosclerosis and sclerotic rim formation, and 18F-FDG PET/CT showed a decreased standardized uptake value, whereas magnetic resonance imaging showed diffuse enhancement of the tumor, nearly the same findings as those at pretreatment. Pathological findings of the surgical specimen after the denosumab treatment showed benign fibrous histiocytoma-like features with complete disappearance of both mononuclear stromal cells and multinuclear osteoclast-like giant cells.
- 7 June 2014
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 111
Open AccessRadiological and pathological characteristics of giant cell tumor of bone treated with denosumab
We describe a case of giant cell tumor of the proximal tibia with skip bone metastases of the ipsilateral femur in a 20-year-old man. After the neoadjuvant treatment with denosumab, plain radiographs and computed tomography showed marked osteosclerosis and sclerotic rim formation, and 18F-FDG PET/CT showed a decreased standardized uptake value, whereas magnetic resonance imaging showed diffuse enhancement of the tumor, nearly the same findings as those at pretreatment. Pathological findings of the surgical specimen after the denosumab treatment showed benign fibrous histiocytoma-like features with complete disappearance of both mononuclear stromal cells and multinuclear osteoclast-like giant cells.